FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56,436 | -18.1% | 143,603 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $68,929 | -71.3% | 143,603 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $240,000 | -41.2% | 143,603 | 0.0% | 0.01% | -42.9% |
| Q2 2022 | $408,000 | -43.5% | 143,603 | 0.0% | 0.01% | -39.1% |
| Q1 2022 | $722,000 | -49.6% | 143,603 | 0.0% | 0.02% | -46.5% |
| Q4 2021 | $1,432,000 | -23.3% | 143,603 | 0.0% | 0.04% | -31.7% |
| Q3 2021 | $1,867,000 | – | 143,603 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|